
Number of publications published per year by Jimenez, Wladimiro. (Source : PubMed)

Distribution of publications types for Jimenez, Wladimiro. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
Gastroenterology
2010;138;1
[Endogenous cannabinoids in liver disease: Many darts for a single target.]
Gastroenterol Hepatol
2009
Vascular endothelial growth factor and angiopoietin-2 play a major role in the pathogenesis of vascular leakage in cirrhotic rats.
Gut
2009;58;2
The hepatic apelin system: a new therapeutic target for liver disease.
Hepatology
2008;48;4

Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats.
Hepatology
2007;46;6

Bradykinin attenuates hepatocellular damage and fibrosis in rats with chronic liver injury.
Gastroenterology
2007;133;6
Gene transduction of an active mutant of akt exerts cytoprotection and reduces graft injury after liver transplantation.
Am. J. Transplant.
2007;7;4
Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats.
J. Hepatol.
2007;46;3
Aquaporin-1 and aquaporin-2 urinary excretion in cirrhosis: Relationship with ascites and hepatorenal syndrome.
Hepatology
2006;44;6
CytoregR inhibits growth and proliferation of human adenocarcinoma cells via induction of apoptosis.
J Carcinog
2006;5
[ See timeline ] [ See all publications ]
means that Jimenez, Wladimiro has 51 papers cited a least 51 times - methodology
Biochemistry and Molecular Genetics Service, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Hospital Clínic, University of Barcelona, Barcelona, Spain.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.